Medium Risk

NGL FINE-CHEM LIMITED

Manufacturing of pharmaceuticals and intermediates for usage in veterinary and human health.

CIN: L24110MH1981PLC025884 FY: - Revenue: ₹354.3 Cr
5.4
ESG Risk
Score /10
Compliance RiskEpr ExposureGhg Intensity

Risk Breakdown

GHG Intensity
5.0
Water Intensity
5.0
Waste Intensity
1.2
EPR Exposure
6.5
Compliance Risk
10.0
HR Risk
3.0
Governance Risk
5.0

Financial Exposure

Est. Compliance Cost₹1–2 crore
EPR ApplicableUnknown
Scope 1 Emissions— tCO2e
Scope 2 Emissions— tCO2e
Water Withdrawal— m³
Waste Generated882.4 T

Governance

Anti-Corruption PolicyYes
Conflict of Interest PolicyUnknown
BRSR AssuranceNone
Assurance Provider

Double Materiality

Financial Materiality5.4
Impact Materiality4.6
QuadrantFinancially Material

Supply Chain

MSME Sourcing0.4%
Lifecycle AssessmentNo
Product ReclaimYes

Material Risks

e-waste

AI Risk Summary

**Financial Risk Summary: NGL Fine-Chem Limited** NGL Fine-Chem's largest financial exposure stems from undefined Extended Producer Responsibility (EPR) obligations (6.5/10 risk score), which could impose unquantified take-back and recycling liabilities on pharmaceutical packaging and intermediates—a material cost not yet provisioned. The company faces critical compliance risk (10.0/10) under SEBI BRSR Core Expansion rules, with potential enforcement action and delisting exposure if environmental disclosures remain incomplete; immediate priority is clarifying EPR applicability and quantifying the estimated ₹1–2 crore compliance remediation cost. Water and GHG intensity risks (both 5.0/10) present moderate operational exposure, though missing Scope 1 and 2 emissions data signals incomplete greenhouse gas accounting, which delays carbon pricing liability assessment under India's emerging Carbon Credit Trading System (₹600–900/tonne benchmark). With ₹354.3 crore revenue and medium ESG risk profile, NGL must urgently formalize EPR compliance strategy and fill emissions reporting gaps to avoid regulatory penalties

Source: NGL FINE-CHEM LIMITED BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.

← Back to ESG Quotient Dashboard Share on LinkedIn Browse all companies →